Showing results (111-120 of 265) with videos related to

Sort By:
Pageof 27
Bone Marrow Transplantation|November 1, 1995
Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infectionK Clarke, J Szer, M Shelton, et al.
International Journal of Laboratory Hematology|April 8, 2014
Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disordersR Agarwal, P Chapple, M Brown, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 23, 2004
[Registration of clinical trials: a statement from the International Committee of Medical Journal Editors]C DeAngelis, J M Drazen, F A Frizelle, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 13, 2012
Hepatitis B serological changes following allogeneic bone marrow transplantationB W Teh, M A Slavin, J Szer, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 2, 2016
Interruption of enzyme replacement therapy in Gaucher diseaseJ Goldblatt, J M Fletcher, J McGill, et al.
Internal Medicine Journal|August 17, 2006
Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantationA B D'Souza, A P Grigg, J Szer, et al.
Bone Marrow Transplantation|February 1, 1993
Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMTJ Szer, A P Grigg, G L Phillips, et al.
Internal Medicine Journal|September 7, 2013
Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspectiveS V Gordon, I Nivison-Smith, J Szer, et al.
Internal Medicine Journal|August 2, 2001
Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantationA Grigg, K Kannan, A P Schwarer, et al.
Bone Marrow Transplantation|April 10, 1999
Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphomaA Grigg, P Bardy, K Byron, et al.
Pageof 27